• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全基因组规模代谢建模预测神经精神疾病的生物标志物和治疗靶点。

Genome-scale metabolic modelling predicts biomarkers and therapeutic targets for neuropsychiatric disorders.

作者信息

Moolamalla S T R, Vinod P K

机构信息

Center for Computational Natural Sciences and Bioinformatics, International Institute of Information Technology, Hyderabad, 500032, India.

Center for Computational Natural Sciences and Bioinformatics, International Institute of Information Technology, Hyderabad, 500032, India.

出版信息

Comput Biol Med. 2020 Oct;125:103994. doi: 10.1016/j.compbiomed.2020.103994. Epub 2020 Sep 17.

DOI:10.1016/j.compbiomed.2020.103994
PMID:32980779
Abstract

Distinguishing neuropsychiatric disorders is challenging due to the overlap in symptoms and genetic risk factors. People suffering from these disorders face personal and professional challenges. Understanding the dysregulation of brain metabolism under disease condition can aid in effective diagnosis and in developing treatment strategies based on the metabolism. In this study, we reconstructed the metabolic network of three major neuropsychiatric disorders, schizophrenia (SCZ), bipolar disorder (BD) and major depressive disorder (MDD) using transcriptomic data and constrained based modelling approach. We integrated brain transcriptomic data from six independent studies with a recent comprehensive genome-scale metabolic model Recon3D. The analysis of the reconstructed network revealed the flux-level alterations in the peroxisome-mitochondria-golgi axis in neuropsychiatric disorders. We also extracted reporter metabolites and pathways that distinguish these three neuropsychiatric disorders. We found differences with respect to fatty acid oxidation, aromatic and branched chain amino acid metabolism, bile acid synthesis, glycosaminoglycans synthesis and modifications, and phospholipid metabolism. Further, we predicted network perturbations that transform the disease metabolic state to a healthy metabolic state for each disorder. These analyses provide local and global views of the metabolic changes in SCZ, BD and MDD, which may have clinical implications.

摘要

由于症状和遗传风险因素存在重叠,鉴别神经精神疾病具有挑战性。患有这些疾病的人面临着个人和职业方面的挑战。了解疾病状态下大脑代谢的失调情况有助于进行有效的诊断,并基于代谢情况制定治疗策略。在本研究中,我们利用转录组数据和基于约束的建模方法,重建了三种主要神经精神疾病——精神分裂症(SCZ)、双相情感障碍(BD)和重度抑郁症(MDD)的代谢网络。我们将来自六项独立研究的大脑转录组数据与最近一个全面的全基因组规模代谢模型Recon3D进行了整合。对重建网络的分析揭示了神经精神疾病中过氧化物酶体 - 线粒体 - 高尔基体轴上的通量水平变化。我们还提取了可区分这三种神经精神疾病的报告代谢物和代谢途径。我们发现了脂肪酸氧化、芳香族和支链氨基酸代谢、胆汁酸合成、糖胺聚糖合成与修饰以及磷脂代谢方面的差异。此外,我们预测了针对每种疾病可将疾病代谢状态转变为健康代谢状态的网络扰动。这些分析提供了精神分裂症、双相情感障碍和重度抑郁症代谢变化的局部和全局视图,可能具有临床意义。

相似文献

1
Genome-scale metabolic modelling predicts biomarkers and therapeutic targets for neuropsychiatric disorders.全基因组规模代谢建模预测神经精神疾病的生物标志物和治疗靶点。
Comput Biol Med. 2020 Oct;125:103994. doi: 10.1016/j.compbiomed.2020.103994. Epub 2020 Sep 17.
2
Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents.鉴定青少年中重度抑郁症、双相情感障碍和精神分裂症的血浆代谢特征。
Transl Psychiatry. 2024 Mar 26;14(1):163. doi: 10.1038/s41398-024-02886-z.
3
Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder.尸检后转录谱分析显示精神分裂症中炎症广泛增加:在与被诊断为精神分裂症、双相或重度抑郁障碍的患者相匹配的四联体对照中,比较前额叶皮层、纹状体和海马。
Transl Psychiatry. 2019 May 23;9(1):151. doi: 10.1038/s41398-019-0492-8.
4
Gene Regulatory Network of Dorsolateral Prefrontal Cortex: a Master Regulator Analysis of Major Psychiatric Disorders.背外侧前额叶皮层的基因调控网络:主要精神疾病的主调控因子分析。
Mol Neurobiol. 2020 Mar;57(3):1305-1316. doi: 10.1007/s12035-019-01815-2. Epub 2019 Nov 14.
5
Exploring the neuropsychiatric spectrum using high-content functional analysis of single-cell signaling networks.利用单细胞信号网络的高内涵功能分析探索神经精神谱系。
Mol Psychiatry. 2020 Oct;25(10):2355-2372. doi: 10.1038/s41380-018-0123-4. Epub 2018 Jul 23.
6
BDgene: a genetic database for bipolar disorder and its overlap with schizophrenia and major depressive disorder.BDgene:双相情感障碍及其与精神分裂症和重度抑郁症重叠的遗传数据库。
Biol Psychiatry. 2013 Nov 15;74(10):727-33. doi: 10.1016/j.biopsych.2013.04.016. Epub 2013 Jun 10.
7
Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.用于鉴定神经精神疾病生物标志物的代谢组学工具。
Neurobiol Dis. 2009 Aug;35(2):165-76. doi: 10.1016/j.nbd.2009.02.019. Epub 2009 Mar 19.
8
The schizophrenia susceptibility gene ZNF804A confers risk of major mood disorders.精神分裂症易感基因 ZNF804A 可增加罹患主要心境障碍的风险。
World J Biol Psychiatry. 2017 Oct;18(7):557-562. doi: 10.1080/15622975.2016.1252466. Epub 2016 Nov 21.
9
Metabolic Insights into Neuropsychiatric Illnesses and Ketogenic Therapies: A Transcriptomic View.代谢洞察神经精神疾病和生酮疗法:转录组学观点。
Int J Mol Sci. 2024 Jul 29;25(15):8266. doi: 10.3390/ijms25158266.
10
TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.严重精神障碍患者单核细胞中 TREM-1 和 DAP12 的表达。EGR3、ATF3 和 PU.1 作为重要的转录因子。
Brain Behav Immun. 2011 Aug;25(6):1162-9. doi: 10.1016/j.bbi.2011.03.006. Epub 2011 Mar 21.

引用本文的文献

1
Hypometabolism in Autism Spectrum Disorder: Insights from Brain and Blood Transcriptomics.自闭症谱系障碍中的低代谢:来自大脑和血液转录组学的见解
Mol Neurobiol. 2025 Apr 15. doi: 10.1007/s12035-025-04941-2.
2
A personalized metabolic modelling approach through integrated analysis of RNA-Seq-based genomic variants and gene expression levels in Alzheimer's disease.一种通过对阿尔茨海默病中基于RNA测序的基因组变异和基因表达水平进行综合分析的个性化代谢建模方法。
Commun Biol. 2025 Mar 27;8(1):502. doi: 10.1038/s42003-025-07941-z.
3
Boltzmann's Theorem Revisited: Inaccurate Time-to-Action Clocks in Affective Disorders.
重新审视玻尔兹曼定理:情感障碍中的行动时间时钟不准确。
Curr Neuropharmacol. 2024;22(11):1762-1777. doi: 10.2174/1570159X22666240315100326.
4
Control Theory and Systems Biology: Potential Applications in Neurodegeneration and Search for Therapeutic Targets.控制理论与系统生物学:在神经退行性疾病中的潜在应用及治疗靶点的寻找。
Int J Mol Sci. 2023 Dec 27;25(1):365. doi: 10.3390/ijms25010365.
5
Transcriptome-based biomarker prediction for Parkinson's disease using genome-scale metabolic modeling.基于转录组的生物标志物预测帕金森病的基因组规模代谢建模。
Sci Rep. 2024 Jan 5;14(1):585. doi: 10.1038/s41598-023-51034-y.
6
Neuroinflammation, Energy and Sphingolipid Metabolism Biomarkers Are Revealed by Metabolic Modeling of Autistic Brains.自闭症大脑的代谢模型揭示神经炎症、能量和鞘脂代谢生物标志物。
Biomedicines. 2023 Feb 16;11(2):583. doi: 10.3390/biomedicines11020583.
7
Context-Specific Genome-Scale Metabolic Modelling and Its Application to the Analysis of COVID-19 Metabolic Signatures.特定背景下的全基因组规模代谢建模及其在新冠病毒代谢特征分析中的应用
Metabolites. 2023 Jan 13;13(1):126. doi: 10.3390/metabo13010126.
8
Inferring miRNA sponge modules across major neuropsychiatric disorders.推断主要神经精神疾病中的微小RNA海绵模块。
Front Mol Neurosci. 2022 Oct 28;15:1009662. doi: 10.3389/fnmol.2022.1009662. eCollection 2022.
9
Review of Current Human Genome-Scale Metabolic Models for Brain Cancer and Neurodegenerative Diseases.脑癌和神经退行性疾病的当前人类全基因组代谢模型综述。
Cells. 2022 Aug 10;11(16):2486. doi: 10.3390/cells11162486.
10
Gut Microbial Dysbiosis and Cognitive Impairment in Bipolar Disorder: Current Evidence.双相情感障碍中的肠道微生物群失调与认知障碍:当前证据
Front Pharmacol. 2022 May 23;13:893567. doi: 10.3389/fphar.2022.893567. eCollection 2022.